A groundbreaking compound may finally give doctors the upper hand against drug-resistant tuberculosis, offering safer and ...

In the study, published in Science Translational Medicine on Nov. 5, researchers identified proteins expressed on the surface ...

A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine ...

A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases.

A Lancet study finds only 40% treatment success for extensively drug-resistant tuberculosis in Europe, with outcomes now ...

Abdominal tuberculosis is a form of extrapulmonary TB caused by Mycobacterium tuberculosis, affecting the intestines, peritoneum, lymph nodes, and sometimes solid organs. It spreads via ingestion of ...

Tuberculosis (TB) infections are surging in England, figures show, as officials urge healthcare providers to look out for ...

A new compound called CMX410 may change the fight against tuberculosis. It targets a weak point in the bacteria’s defenses, ...

The MHRA has approved Siiltibcy, a new skin test that uses recombinant proteins to more accurately detect tuberculosis in ...

During that time, consumption was thought to be caused by hereditary susceptibility and miasmas, or “bad airs,” in the environment. Among the upper class, one of the ways people judged a woman’s ...

TimesMachine is an exclusive benefit for home delivery and digital subscribers. About the Archive This is a digitized version of an article from The Times’s print archive, before the start of online ...